Telmisartan combination launched in Japan for hypertension
This article was originally published in Scrip
Executive Summary
Boehringer Ingelheim and local partner Astellas have launched a combination of telmisartan and the diuretic hydrochlorothiazide in Japan, as Micombi, to treat hypertension.